These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
278 related articles for article (PubMed ID: 34771442)
1. Interaction of Opioids with TLR4-Mechanisms and Ramifications. Gabr MM; Saeed I; Miles JA; Ross BP; Shaw PN; Hollmann MW; Parat MO Cancers (Basel); 2021 Oct; 13(21):. PubMed ID: 34771442 [TBL] [Abstract][Full Text] [Related]
2. Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility. Zhang P; Yang M; Chen C; Liu L; Wei X; Zeng S Front Immunol; 2020; 11():1455. PubMed ID: 32733481 [TBL] [Abstract][Full Text] [Related]
3. The Role of Opioid Receptors in Immune System Function. Eisenstein TK Front Immunol; 2019; 10():2904. PubMed ID: 31921165 [TBL] [Abstract][Full Text] [Related]
4. Structural insights into pharmacophore-assisted in silico identification of protein-protein interaction inhibitors for inhibition of human toll-like receptor 4 - myeloid differentiation factor-2 (hTLR4-MD-2) complex. Mishra V; Pathak C J Biomol Struct Dyn; 2019 May; 37(8):1968-1991. PubMed ID: 29842849 [TBL] [Abstract][Full Text] [Related]
6. Pharmacological characterization of LPS and opioid interactions at the toll-like receptor 4. Stevens CW; Aravind S; Das S; Davis RL Br J Pharmacol; 2013 Mar; 168(6):1421-9. PubMed ID: 23083095 [TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterization of the opioid inactive isomers (+)-naltrexone and (+)-naloxone as antagonists of toll-like receptor 4. Wang X; Zhang Y; Peng Y; Hutchinson MR; Rice KC; Yin H; Watkins LR Br J Pharmacol; 2016 Mar; 173(5):856-69. PubMed ID: 26603732 [TBL] [Abstract][Full Text] [Related]
8. Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae. Grace PM; Ramos KM; Rodgers KM; Wang X; Hutchinson MR; Lewis MT; Morgan KN; Kroll JL; Taylor FR; Strand KA; Zhang Y; Berkelhammer D; Huey MG; Greene LI; Cochran TA; Yin H; Barth DS; Johnson KW; Rice KC; Maier SF; Watkins LR Neuroscience; 2014 Nov; 280():299-317. PubMed ID: 25241065 [TBL] [Abstract][Full Text] [Related]
9. Possible involvement of toll-like receptor 4/myeloid differentiation factor-2 activity of opioid inactive isomers causes spinal proinflammation and related behavioral consequences. Hutchinson MR; Lewis SS; Coats BD; Rezvani N; Zhang Y; Wieseler JL; Somogyi AA; Yin H; Maier SF; Rice KC; Watkins LR Neuroscience; 2010 May; 167(3):880-93. PubMed ID: 20178837 [TBL] [Abstract][Full Text] [Related]
10. Activation of Toll-like receptors by Burkholderia pseudomallei. West TE; Ernst RK; Jansson-Hutson MJ; Skerrett SJ BMC Immunol; 2008 Aug; 9():46. PubMed ID: 18691413 [TBL] [Abstract][Full Text] [Related]
11. Ergosta-7, 9 (11), 22-trien-3β-ol Interferes with LPS Docking to LBP, CD14, and TLR4/MD-2 Co-Receptors to Attenuate the NF-κB Inflammatory Pathway Hsieh WT; Hsu MH; Lin WJ; Xiao YC; Lyu PC; Liu YC; Lin WY; Kuo YH; Chung JG Int J Mol Sci; 2021 Jun; 22(12):. PubMed ID: 34204506 [TBL] [Abstract][Full Text] [Related]
12. The TLR4-Active Morphine Metabolite Morphine-3-Glucuronide Does Not Elicit Macrophage Classical Activation Khabbazi S; Xie N; Pu W; Goumon Y; Parat MO Front Pharmacol; 2016; 7():441. PubMed ID: 27909407 [TBL] [Abstract][Full Text] [Related]
13. Ciprofloxacin and levofloxacin attenuate microglia inflammatory response via TLR4/NF-kB pathway. Zusso M; Lunardi V; Franceschini D; Pagetta A; Lo R; Stifani S; Frigo AC; Giusti P; Moro S J Neuroinflammation; 2019 Jul; 16(1):148. PubMed ID: 31319868 [TBL] [Abstract][Full Text] [Related]
14. MyD88-dependent and -independent signalling via TLR3 and TLR4 are differentially modulated by Δ Fitzpatrick JM; Minogue E; Curham L; Tyrrell H; Gavigan P; Hind W; Downer EJ J Neuroimmunol; 2020 Jun; 343():577217. PubMed ID: 32244040 [TBL] [Abstract][Full Text] [Related]
15. Exploring the LPS/TLR4 signal pathway with small molecules. Peri F; Piazza M; Calabrese V; Damore G; Cighetti R Biochem Soc Trans; 2010 Oct; 38(5):1390-5. PubMed ID: 20863319 [TBL] [Abstract][Full Text] [Related]
16. Tailored Modulation of Cellular Pro-inflammatory Responses With Disaccharide Lipid A Mimetics. Heine H; Adanitsch F; Peternelj TT; Haegman M; Kasper C; Ittig S; Beyaert R; Jerala R; Zamyatina A Front Immunol; 2021; 12():631797. PubMed ID: 33815382 [TBL] [Abstract][Full Text] [Related]
17. Mu opioid receptor activation modulates Toll like receptor 4 in murine macrophages. Franchi S; Moretti S; Castelli M; Lattuada D; Scavullo C; Panerai AE; Sacerdote P Brain Behav Immun; 2012 Mar; 26(3):480-8. PubMed ID: 22240038 [TBL] [Abstract][Full Text] [Related]
19. Induction of tolerance to lipopolysaccharide and mycobacterial components in Chinese hamster ovary/CD14 cells is not affected by overexpression of Toll-like receptors 2 or 4. Medvedev AE; Henneke P; Schromm A; Lien E; Ingalls R; Fenton MJ; Golenbock DT; Vogel SN J Immunol; 2001 Aug; 167(4):2257-67. PubMed ID: 11490013 [TBL] [Abstract][Full Text] [Related]
20. Glycyrrhizin and isoliquiritigenin suppress the LPS sensor toll-like receptor 4/MD-2 complex signaling in a different manner. Honda H; Nagai Y; Matsunaga T; Saitoh S; Akashi-Takamura S; Hayashi H; Fujii I; Miyake K; Muraguchi A; Takatsu K J Leukoc Biol; 2012 Jun; 91(6):967-76. PubMed ID: 22422925 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]